2024 OBJECTIVE

Achieved to date
0%
10M€

10 years

For 10 years, Liryc has pursued a unique research approach that brings together the world’s leading experts. It gathers institutional and industrial players around the same objective: to better prevent and cure heart rhythm diseases. We are the only research institute in the world to dedicate all our work to these diseases and to improve our understanding of the heart’s electrical network. We are bio-electricians of the heart!

2024

We have an ambitious 2020-2024 strategic plan. With your support, it can become a reality. It includes major projects such as research programs for preventing sudden death and treating atrial fibrillation, creation of a cardiac bioengineering platform, acquisition of a latest-generation scanner and development of a graduate school for cardiac electrophysiology.

10 M€

At Liryc, we are committed to not only understanding, curing and preventing such diseases on a daily basis, but also disseminating our knowledge throughout the world. Our teams are up against some considerable challenges. €10 million are needed to reduce heart rhythm disorders.

There is still a lot to do, but together with your help we can move faster and succeed.

THE 3 AREAS OF RESEARCH

RESEARCH & CARE

ACCELERATE RESEARCH AND TREATMENTS

Recherches Soins
Innovations Technologiques
TECHNOLOGICAL INNOVATIONS

GIVE PERSONALIZED THERAPIES CONCRETE FORM

EDUCATION & TRAINING

SHARE OUR KNOWLEDGE AND EXPERTISE

Enseignement Formation

In the spotlight

1716555624842

Charity event in Chicago

On Wednesday, May 22nd, 2024, Dr. Mélèze Hocini, Deputy General Director of Liryc, had the honor of presenting the missions
Voir plus
2

READ THE 2023 ANNUAL REVIEW OF THE CAMPAIGN

The year 2023 was marked by an unprecedented surge of generosity from our donors. Together, we continue our mission to
Voir plus
liryc institute vip reception

Charity event in Chicago

On Wednesday, December 6, twenty guests gathered in Chicago to build awareness and support for the missions of Liryc in
Voir plus